skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
Slam-Dunks, Aces or Triple Crowns?

Last year, Christine Blazynski, Head of Innovation, reported on the clinical trial landscape for trials that completed during 2014, highlighting diseases that enjoyed success and the companies backing those trials.

As of February 11, 2016, Trialtrove reported a total of 3679 industry-sponsored Phase I through Phase III/IV trials that were terminated or completed during 2015 [2]. Of these, 3220 completed while 459 trials were terminated. Of the latter trial group, a mere 14 terminated due to early positive efficacy.

Highlights in this white paper include:

  • Landscape overview
  • Disease landscape
  • Leading industry sponsors
  • Cancer trial completions
  • Top 5 disease trial metrics
Clinical trial landscape

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: